Poster Presentations at the AACR 2024 Annual Meeting for OBI-992 and GlycOBI™ ADC platform

Title: OBI-992, a novel TROP2 targeting antibody-drug conjugate, displayed excellent antitumor efficacy in various animal models Abstract presentation number: 1893 / Poster number 23/4 PDF LINK Title: In vitro characterization of a novel TROP2-targeting antibody-drug conjugate OBI-992 Abstract presentation number: 3130 / Poster number 21/11 PDF LINK Title: Development of a novel site-specific ADC glycan […]